---
schema_version: "secwatch.filing_event.v1"
accession: "0001295947-25-000037"
form_type: "8-K"
ticker: "PBH"
cik: "0001295947"
company_name: "Prestige Consumer Healthcare Inc."
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-16T23:24:42.880328+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Prestige Consumer Q2 adj EPS $1.07 beats prior year; raises FY adj EPS guidance to $4.54-$4.58

## Summary
- Q2 revenue $274.1M (-3.4% YoY); diluted EPS $0.86 vs $1.09; adjusted EPS $1.07.
- Raises FY2026 adjusted diluted EPS outlook to $4.54-$4.58 (high end of prior range).
- Repurchased ~1.1M shares in Q2 for $75M; cumulative 1.6M shares in H1 for $109.8M.
- Clear Eyes supply constraints drove OTC revenue decline; expects improvement in H2 via capacity rebuild.
- Free cash flow guidance reaffirmed at $245M+; covenant leverage 2.4x.

## SEC filing metadata
- accession: 0001295947-25-000037
- form_type: 8-K
- ticker: PBH
- cik: 0001295947
- company_name: Prestige Consumer Healthcare Inc.
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1295947/000129594725000037/0001295947-25-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1295947/000129594725000037/pbh-20251106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001295947-25-000037
- JSON: https://secwatch.observer/filing/0001295947-25-000037.json
- Plain text: https://secwatch.observer/filing/0001295947-25-000037.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.